Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Enhancer reprogramming promotes pancreatic cancer progression and metastasis

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

OTHER RELATED OMICS DATASETS IN: PRJNA387949PRJNA388127PRJNA387924PRJNA388090

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE99311 | GEO | 2017/07/31

SECONDARY ACCESSION(S): PRJNA388090

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis.

Project description:Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal human malignancies, owing in part to its propensity for metastasis. Here, we used an organoid culture system to investigate how transcription and the enhancer landscape become altered during discrete stages of disease progression in a PDA mouse model. This approach revealed that the metastatic transition is accompanied by massive and recurrent alterations in enhancer activity. We implicate the pioneer factor FOXA1 as a driver of enhancer activation in this system, a mechanism that renders PDA cells more invasive and less anchorage-dependent for growth in vitro, as well as more metastatic in vivo. In this context, FOXA1-dependent enhancer reprogramming activates a transcriptional program of embryonic foregut endoderm. Collectively, our study implicates enhancer reprogramming, FOXA1 upregulation, and a retrograde developmental transition in PDA metastasis.

| S-EPMC5726277 | biostudies-literature

Enhancer reprogramming promotes the activation of cancer-associated fibroblasts and breast cancer metastasis

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-12-09 | GSE196404 | GEO

Enhancer reprogramming promotes pancreatic cancer progression and metastasis

Project description:Enhancer reprogramming promotes pancreatic cancer progression and metastasis

| PRJNA388090 | ENA

Enhancer reprogramming promotes pancreatic cancer progression and metastasis [RNA-seq]

Project description:Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal human malignancies, owing in part to its propensity for metastasis. Here, we used an organoid culture system to investigate how transcription and the enhancer landscape become altered during each stage of PDA progression. This approach revealed that the metastatic transition is accompanied by massive, and recurrent alterations in enhancer activity. We implicate the transcription factors FOXA1 and GATA5 as drivers of enhancer activation in this system, a mechanism that we show renders PDA cells more invasive and less anchorage-dependent for growth in vitro, as well as more metastatic in vivo. FOXA1 and GATA5 were found to activate a foregut endoderm transcriptional program in PDA cells, without altering genes associated with the epithelial-to- mesenchymal transition. Collectively, our study implicates FOXA1/GATA5 upregulation, enhancer reprogramming, and a novel retrograde developmental transition in PDA progression and metastasis.

2017-07-31 | GSE99310 | GEO

Enhancer reprogramming promotes pancreatic cancer progression and metastasis [ChIP-seq]

Project description:Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal human malignancies, owing in part to its propensity for metastasis. Here, we used an organoid culture system to investigate how transcription and the enhancer landscape become altered during each stage of PDA progression. This approach revealed that the metastatic transition is accompanied by massive, and recurrent alterations in enhancer activity. We implicate the transcription factors FOXA1 and GATA5 as drivers of enhancer activation in this system, a mechanism that we show renders PDA cells more invasive and less anchorage-dependent for growth in vitro, as well as more metastatic in vivo. FOXA1 and GATA5 were found to activate a foregut endoderm transcriptional program in PDA cells, without altering genes associated with the epithelial-to- mesenchymal transition. Collectively, our study implicates FOXA1/GATA5 upregulation, enhancer reprogramming, and a novel retrograde developmental transition in PDA progression and metastasis.

2017-07-31 | GSE99284 | GEO

Enhancer reprogramming promotes pancreatic cancer progression and metastasis [ATAC-seq]

Project description:Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal human malignancies, owing in part to its propensity for metastasis. Here, we used an organoid culture system to investigate how transcription and the enhancer landscape become altered during each stage of PDA progression. This approach revealed that the metastatic transition is accompanied by massive, and recurrent alterations in enhancer activity. We implicate the transcription factors FOXA1 and GATA5 as drivers of enhancer activation in this system, a mechanism that we show renders PDA cells more invasive and less anchorage-dependent for growth in vitro, as well as more metastatic in vivo. FOXA1 and GATA5 were found to activate a foregut endoderm transcriptional program in PDA cells, without altering genes associated with the epithelial-to- mesenchymal transition. Collectively, our study implicates FOXA1/GATA5 upregulation, enhancer reprogramming, and a novel retrograde developmental transition in PDA progression and metastasis.

2017-07-31 | GSE99275 | GEO

Engrailed-1 Promotes Pancreatic Cancer Metastasis

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-12-19 | GSE228805 | GEO

Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2016-10-23 | E-GEOD-63126 | biostudies-arrayexpress

LSD1 promotes castration-resistant prostate cancer progression

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2016-06-30 | E-GEOD-77763 | biostudies-arrayexpress

SAP30 promotes breast cancer progression and metastasis by gene activation

Project description:This SuperSeries is composed of the SubSeries listed below.